Trials / Not Yet Recruiting
Not Yet RecruitingNCT06300216
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this multicenter, open-label, observational study is to evaluate the safety and efficacy of octreotide microspheres in the treatment of advanced neuroendocrine tumors in real clinical practice, especially to evaluate the treatment of octreotide microspheres in various subgroups of neuroendocrine tumor patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Octreotide microspheres | 20mg/30mg Q4W |
Timeline
- Start date
- 2024-03-26
- Primary completion
- 2027-11-26
- Completion
- 2028-05-26
- First posted
- 2024-03-08
- Last updated
- 2024-03-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06300216. Inclusion in this directory is not an endorsement.